Latest Posts

CRISPR/Cas9-Mediated Gene Knockout to Address Primary Hyperoxaluria

February 18, 2020 4:46 pm Published by Tiziani Whitmyre

Using Lipid Nanoparticles to Efficiently Deliver CRISPR/Cas9 for Genome Editing

February 18, 2020 4:44 pm Published by Tiziani Whitmyre

Development of NTLA-2001, a CRISPR/Cas9 Genome Editing Therapeutic for the Treatment of ATTR

February 18, 2020 4:43 pm Published by Tiziani Whitmyre

CRISPR/Cas9-Mediated Gene Knockout to Address Primary Hyperoxaluria

February 18, 2020 4:42 pm Published by Tiziani Whitmyre

CRISPR/Cas9-Mediated Targeted Insertion of Human F9 Achieves Therapeutic Circulating Protein Levels in Mice and Non-Human Primates

February 18, 2020 4:42 pm Published by Tiziani Whitmyre

Delivering on the therapeutic potential of CRISPR/Cas9: Development of an LNP-mediated genome editing therapeutic for the treatment of ATTR

February 18, 2020 4:41 pm Published by Tiziani Whitmyre

Development of NTLA-1001: First-in-Class, LNP-CRISPR/Cas9 Mediated Genome Editing Therapeutic for the Treatment of ATTR

February 18, 2020 4:40 pm Published by Tiziani Whitmyre

Engineering of Highly Functional and Specific Transgenic T Cell Receptor (TCR) T Cells Using CRISPR-Mediated In-Locus Insertion Combined with Endogenous TCR Knockout

February 18, 2020 4:39 pm Published by Tiziani Whitmyre

Rescue of Amyloid Deposition Phenotype After Single-Treatment CRISPR/Cas9 Gene Editing in a Humanized Mouse Model of ATTR

February 18, 2020 4:38 pm Published by Tiziani Whitmyre

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing

February 18, 2020 4:36 pm Published by Tiziani Whitmyre

« Previous 1 2 3

Menu